William E. Kennard - Oct 1, 2021 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anna Nazarenko, Authorized Signer
Stock symbol
MET
Transactions as of
Oct 1, 2021
Transactions value $
$37,512
Form type
4
Date filed
10/5/2021, 04:34 PM
Previous filing
Sep 16, 2021
Next filing
Nov 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $37.5K +600 +2.02% $62.52 30.3K Oct 1, 2021 Direct F1
holding MET Common Stock 10 Oct 1, 2021 By the MetLife Policyholder Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. The director deferred receipt under the MetLife Deferred Compensation Plan for Non-Management Directors.
F2 Shares held in trust under the MetLife Policyholder Trust established to hold shares of MetLife, Inc. common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney